secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001174947-23-000616
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q1 sales $295.5M (+21.9% YoY); raises FY 2023 revenue and EPS guidance
-----------------------------------------------------------------------------

- Sales $295.5M (+21.9% as reported; +25.1% constant currency); acquisitions contributed ~570 bps growth.
- GAAP diluted EPS $0.06 (down 87.2% YoY); adjusted diluted EPS $0.66 (down 5.7% YoY).
- Raises FY 2023 revenue guidance to $1.205B-$1.250B from $1.170B-$1.220B.
- Raises FY 2023 adjusted EPS guidance to $3.30-$3.50 from $3.20-$3.45.
- Adjusted EBITDA $51.2M (17.3% margin) vs $43.7M (18.0% margin) in Q1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/0001174947-23-000616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/form8k-30039_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-23-000616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer